The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Animal-derived Immune Globulin Products-Global Market Insights and Sales Trends 2025

Animal-derived Immune Globulin Products-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1838230

No of Pages : 95

Ask Your Query

Report Description
Table of Content

Synopsis
Immune globulin (Ig) short-term protection against hepatitis A and measles
The global Animal-derived Immune Globulin Products market size is expected to reach US$ 1726.3 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Animal-derived Immune Globulin Products in various end use industries. The expanding demands from the Immunodeficiency, Autoimmune Disease and Acute Infection,, are propelling Animal-derived Immune Globulin Products market. IVIg Liquid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IVIg Powder segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Animal-derived Immune Globulin Products market, driven by demand from China, the second largest economy with some signs of stabilising, the Animal-derived Immune Globulin Products market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal-derived Immune Globulin Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal-derived Immune Globulin Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal-derived Immune Globulin Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal-derived Immune Globulin Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal-derived Immune Globulin Products covered in this report include Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi and BTG Specialty Pharmaceuticals, etc.
The global Animal-derived Immune Globulin Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Rare Disease Therapeutics
Bioclon Institute
Merck & Co
Sanofi
BTG Specialty Pharmaceuticals
Global Animal-derived Immune Globulin Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal-derived Immune Globulin Products market, Segment by Type:
IVIg Liquid
IVIg Powder
Global Animal-derived Immune Globulin Products market, by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Animal-derived Immune Globulin Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Animal-derived Immune Globulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Animal-derived Immune Globulin Products Market Overview
1.1 Animal-derived Immune Globulin Products Product Overview
1.2 Animal-derived Immune Globulin Products Market Segment by Type
1.2.1 IVIg Liquid
1.2.2 IVIg Powder
1.3 Global Animal-derived Immune Globulin Products Market Size by Type
1.3.1 Global Animal-derived Immune Globulin Products Market Size Overview by Type (2018-2029)
1.3.2 Global Animal-derived Immune Globulin Products Historic Market Size Review by Type (2018-2023)
1.3.3 Global Animal-derived Immune Globulin Products Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Animal-derived Immune Globulin Products Sales Breakdown by Type (2018-2023)
1.4.2 Europe Animal-derived Immune Globulin Products Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Animal-derived Immune Globulin Products Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Animal-derived Immune Globulin Products Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Animal-derived Immune Globulin Products Sales Breakdown by Type (2018-2023)
2 Global Animal-derived Immune Globulin Products Market Competition by Company
2.1 Global Top Players by Animal-derived Immune Globulin Products Sales (2018-2023)
2.2 Global Top Players by Animal-derived Immune Globulin Products Revenue (2018-2023)
2.3 Global Top Players by Animal-derived Immune Globulin Products Price (2018-2023)
2.4 Global Top Manufacturers Animal-derived Immune Globulin Products Manufacturing Base Distribution, Sales Area, Product Type
2.5 Animal-derived Immune Globulin Products Market Competitive Situation and Trends
2.5.1 Animal-derived Immune Globulin Products Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Animal-derived Immune Globulin Products Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal-derived Immune Globulin Products as of 2022)
2.7 Date of Key Manufacturers Enter into Animal-derived Immune Globulin Products Market
2.8 Key Manufacturers Animal-derived Immune Globulin Products Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Animal-derived Immune Globulin Products Status and Outlook by Region
3.1 Global Animal-derived Immune Globulin Products Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Animal-derived Immune Globulin Products Historic Market Size by Region
3.2.1 Global Animal-derived Immune Globulin Products Sales in Volume by Region (2018-2023)
3.2.2 Global Animal-derived Immune Globulin Products Sales in Value by Region (2018-2023)
3.2.3 Global Animal-derived Immune Globulin Products Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Animal-derived Immune Globulin Products Forecasted Market Size by Region
3.3.1 Global Animal-derived Immune Globulin Products Sales in Volume by Region (2024-2029)
3.3.2 Global Animal-derived Immune Globulin Products Sales in Value by Region (2024-2029)
3.3.3 Global Animal-derived Immune Globulin Products Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Animal-derived Immune Globulin Products by Application
4.1 Animal-derived Immune Globulin Products Market Segment by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Animal-derived Immune Globulin Products Market Size by Application
4.2.1 Global Animal-derived Immune Globulin Products Market Size Overview by Application (2018-2029)
4.2.2 Global Animal-derived Immune Globulin Products Historic Market Size Review by Application (2018-2023)
4.2.3 Global Animal-derived Immune Globulin Products Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Animal-derived Immune Globulin Products Sales Breakdown by Application (2018-2023)
4.3.2 Europe Animal-derived Immune Globulin Products Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Animal-derived Immune Globulin Products Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Animal-derived Immune Globulin Products Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Animal-derived Immune Globulin Products Sales Breakdown by Application (2018-2023)
5 North America Animal-derived Immune Globulin Products by Country
5.1 North America Animal-derived Immune Globulin Products Historic Market Size by Country
5.1.1 North America Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Animal-derived Immune Globulin Products Sales in Volume by Country (2018-2023)
5.1.3 North America Animal-derived Immune Globulin Products Sales in Value by Country (2018-2023)
5.2 North America Animal-derived Immune Globulin Products Forecasted Market Size by Country
5.2.1 North America Animal-derived Immune Globulin Products Sales in Volume by Country (2024-2029)
5.2.2 North America Animal-derived Immune Globulin Products Sales in Value by Country (2024-2029)
6 Europe Animal-derived Immune Globulin Products by Country
6.1 Europe Animal-derived Immune Globulin Products Historic Market Size by Country
6.1.1 Europe Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Animal-derived Immune Globulin Products Sales in Volume by Country (2018-2023)
6.1.3 Europe Animal-derived Immune Globulin Products Sales in Value by Country (2018-2023)
6.2 Europe Animal-derived Immune Globulin Products Forecasted Market Size by Country
6.2.1 Europe Animal-derived Immune Globulin Products Sales in Volume by Country (2024-2029)
6.2.2 Europe Animal-derived Immune Globulin Products Sales in Value by Country (2024-2029)
7 Asia-Pacific Animal-derived Immune Globulin Products by Region
7.1 Asia-Pacific Animal-derived Immune Globulin Products Historic Market Size by Region
7.1.1 Asia-Pacific Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Animal-derived Immune Globulin Products Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Animal-derived Immune Globulin Products Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Animal-derived Immune Globulin Products Forecasted Market Size by Region
7.2.1 Asia-Pacific Animal-derived Immune Globulin Products Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Animal-derived Immune Globulin Products Sales in Value by Region (2024-2029)
8 Latin America Animal-derived Immune Globulin Products by Country
8.1 Latin America Animal-derived Immune Globulin Products Historic Market Size by Country
8.1.1 Latin America Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Animal-derived Immune Globulin Products Sales in Volume by Country (2018-2023)
8.1.3 Latin America Animal-derived Immune Globulin Products Sales in Value by Country (2018-2023)
8.2 Latin America Animal-derived Immune Globulin Products Forecasted Market Size by Country
8.2.1 Latin America Animal-derived Immune Globulin Products Sales in Volume by Country (2024-2029)
8.2.2 Latin America Animal-derived Immune Globulin Products Sales in Value by Country (2024-2029)
9 Middle East and Africa Animal-derived Immune Globulin Products by Country
9.1 Middle East and Africa Animal-derived Immune Globulin Products Historic Market Size by Country
9.1.1 Middle East and Africa Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Animal-derived Immune Globulin Products Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Animal-derived Immune Globulin Products Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Animal-derived Immune Globulin Products Forecasted Market Size by Country
9.2.1 Middle East and Africa Animal-derived Immune Globulin Products Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Animal-derived Immune Globulin Products Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Animal-derived Immune Globulin Products Products Offered
10.1.5 Pfizer Recent Development
10.2 Rare Disease Therapeutics
10.2.1 Rare Disease Therapeutics Company Information
10.2.2 Rare Disease Therapeutics Introduction and Business Overview
10.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Products Offered
10.2.5 Rare Disease Therapeutics Recent Development
10.3 Bioclon Institute
10.3.1 Bioclon Institute Company Information
10.3.2 Bioclon Institute Introduction and Business Overview
10.3.3 Bioclon Institute Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bioclon Institute Animal-derived Immune Globulin Products Products Offered
10.3.5 Bioclon Institute Recent Development
10.4 Merck & Co
10.4.1 Merck & Co Company Information
10.4.2 Merck & Co Introduction and Business Overview
10.4.3 Merck & Co Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck & Co Animal-derived Immune Globulin Products Products Offered
10.4.5 Merck & Co Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sanofi Animal-derived Immune Globulin Products Products Offered
10.5.5 Sanofi Recent Development
10.6 BTG Specialty Pharmaceuticals
10.6.1 BTG Specialty Pharmaceuticals Company Information
10.6.2 BTG Specialty Pharmaceuticals Introduction and Business Overview
10.6.3 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2018-2023)
10.6.4 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Products Offered
10.6.5 BTG Specialty Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Animal-derived Immune Globulin Products Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Animal-derived Immune Globulin Products Industrial Chain Analysis
11.4 Animal-derived Immune Globulin Products Market Dynamics
11.4.1 Animal-derived Immune Globulin Products Industry Trends
11.4.2 Animal-derived Immune Globulin Products Market Drivers
11.4.3 Animal-derived Immune Globulin Products Market Challenges
11.4.4 Animal-derived Immune Globulin Products Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Animal-derived Immune Globulin Products Distributors
12.3 Animal-derived Immune Globulin Products Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}